Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity - (Unaudited)

v3.22.2
Consolidated Statements of Equity - (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Noncontrolling interests
Noncontrolling interests
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling interests
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2020 32,600,000     1,000 32,556,303 32,557,303                  
Beginning balance at Dec. 31, 2020 $ 529,486 $ 0 $ 529,486 $ 0 $ 3 $ 3 $ 496,174 $ (3) $ 496,171 $ 32,011 $ 0 $ 32,011 $ 1,301 $ 0 $ 1,301
Increase (Decrease) in Shareholders' Equity                              
Recapitalization transaction, net of fees and deferred taxes (in shares)       13,673,722                      
Recapitalization transaction, net of fees and deferred taxes 31,662     $ 2     31,660                
Vesting of restricted stock units (in shares)       50,066                      
Vesting of restricted stock units 0                            
Stock-based compensation expense 2,829           2,829                
Net income (loss) 3,564                 3,590     (26)    
Ending balance (in shares) at Jun. 30, 2021       46,281,091                      
Ending balance at Jun. 30, 2021 567,541     $ 5     530,660     35,601     1,275    
Beginning balance (in shares) at Mar. 31, 2021       46,231,025                      
Beginning balance at Mar. 31, 2021 556,658     $ 5     530,427     24,937     1,289    
Increase (Decrease) in Shareholders' Equity                              
Recapitalization transaction, net of fees and deferred taxes (220)           (220)                
Vesting of restricted stock units (in shares)       50,066                      
Vesting of restricted stock units 0                            
Stock-based compensation expense 453           453                
Net income (loss) 10,650                 10,664     (14)    
Ending balance (in shares) at Jun. 30, 2021       46,281,091                      
Ending balance at Jun. 30, 2021 $ 567,541     $ 5     530,660     35,601     1,275    
Beginning balance (in shares) at Dec. 31, 2021 46,281,091     46,281,091                      
Beginning balance at Dec. 31, 2021 $ 621,397     $ 5     535,345     84,797     1,250    
Increase (Decrease) in Shareholders' Equity                              
Shares issued under share based awards (in shares)       204,065                      
Cash paid for shares withheld for taxes (848)           (848)                
Stock-based compensation expense 1,872           1,872                
Repurchase of common stock (in shares)       (5,559,577)                      
Repurchase of common stock (40,200)     $ (1)     (40,199)                
Contributions from noncontrolling interests 55,000                       55,000    
Net income (loss) $ 27,915                 28,000     (85)    
Ending balance (in shares) at Jun. 30, 2022 40,925,579     40,925,579                      
Ending balance at Jun. 30, 2022 $ 665,136     $ 4     496,170     112,797     56,165    
Beginning balance (in shares) at Mar. 31, 2022       46,047,328                      
Beginning balance at Mar. 31, 2022 630,480     $ 5     531,367     97,862     1,246    
Increase (Decrease) in Shareholders' Equity                              
Cash paid for shares withheld for taxes (176)           (176)                
Stock-based compensation expense 1,354           1,354                
Repurchase of common stock (in shares)       (5,121,749)                      
Repurchase of common stock (36,376)     $ (1)     (36,375)                
Contributions from noncontrolling interests 55,000                       55,000    
Net income (loss) $ 14,854                 14,935     (81)    
Ending balance (in shares) at Jun. 30, 2022 40,925,579     40,925,579                      
Ending balance at Jun. 30, 2022 $ 665,136     $ 4     $ 496,170     $ 112,797     $ 56,165